Uncategorized

It’s a major win for bankrupt Steward, which has sought to offload its physician group since December. 

Selling the business, called Vantive, rather than spinning it off, should maximize shareholder value and give Baxter more flexibility to pursue other growth opportunities, the company said.

While some biopharma companies beat expectations, others fell short for various reasons, with some deciding to return or axe assets.

The layoffs are intended to help provide an operating runway into the fourth quarter of 2026.

On the heels of last week’s FDA rejection of Lykos’ MDMA-assisted PTSD therapy, Atai announced Tuesday positive preliminary results from a Phase Ib depression study.

Las supersticiones han sido parte integral de la cultura mexicana desde tiempos ancestrales, y los juegos de azar no son la excepción. Desde amuletos hasta rituales, los mexicanos han desarrollado una amplia gama de creencias para atraer la suerte y aumentar sus posibilidades de ganar. De hec …

  La seguridad laboral es una necesidad esencial que ha evolucionado significativamente a lo largo del tiempo como resultado de una serie de eventos históricos y desarrollos legislativos que han ido moldeando lo que hoy conocemos como un pilar fundamental en el ámbito laboral. …

The Swiss company’s monoclonal antibody Nemluvio is also undergoing regulatory review for atopic dermatitis, which is a potentially larger market for the first-in-class IL-31 blocker.

The acquisition announced Monday will give Crown access to Revance’s Daxxify, a competitor to AbbVie’s Botox, which is indicated for frown lines and for cervical dystonia.

By the end of the year, Novo Nordisk intends to make a regulatory filing for the combination of its icodec and semaglutide, keeping its once-weekly insulin program afloat.